Ticker LaunchReverse merger · Completed · TVRD
Tvardi Therapeutics, Inc.
Reverse merger with Cara Therapeutics, Inc.
Tvardi Therapeutics, Inc. merged into Cara Therapeutics, Inc., a Nasdaq-listed biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Dec 18, 2024 and closed on Apr 15, 2025. The combined company trades as Tvardi Therapeutics, Inc. (TVRD) on Nasdaq.
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oral small-molecule therapies targeting STAT3 for fibrosis-driven diseases, with a lead program in idiopathic pulmonary fibrosis and a second in hepatocellular carcinoma.
- Status
- Completed
- Private company
- Tvardi Therapeutics, Inc.
- Public company
- Cara Therapeutics, Inc.
- Public company business before
- Nasdaq-listed biopharmaceutical company
- Announced
- Dec 18, 2024
- Closed
- Apr 15, 2025
- Combined company
- Tvardi Therapeutics, Inc. (TVRD)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Apr 15, 2025
- Closing press release / exhibit
- Announcement press release
- All filings on EDGAR CIK 1346830
Other completed reverse mergers
- Jade Biosciencesinto Aerovate Therapeutics, Inc. · Apr 28, 2025
- SRx Health Solutions, Inc.into Better Choice Company, Inc. · Apr 24, 2025
- METech Recycling, Inc.into First America Resources Corp · Apr 21, 2025
- Synthesis Analytics Production Ltdinto Edgemode, Inc. · Apr 7, 2025
- Kalaris Tx, Inc.into AlloVir, Inc. · Mar 18, 2025
- Premier Air Charter, Inc.into Altair International Corp. · Mar 5, 2025